Having trouble accessing articles? Reset your cache.

Complex generic first to show ‘virtual’ bioequivalence with Certara’s modeling system

FDA's approval of an undisclosed complex generic via the ANDA pathway marks the first use of Certara's modeling

Read the full 184 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE